Christopher R. Loose, Chief Scientific Officer at Frequency Therapeutics, Inc. (FREQ), sold 16,000 shares at $24.00 ($376K) on 2020-11-09, disclosed to the SEC on 2020-11-09.
Open-market sale of $376k FREQ by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.00 | 8,000 | $184K | 48.9% |
| 2 | $24.00 | 8,000 | $192K | 51.1% |
| Total | $23.50 avg | 16,000 | $376K | 100% |
| Filing → |
| FREQ | SELL | 2023-07-25 | $2K | — | Filing → |
| FREQ | SELL | 2023-07-21 | $2K | — | Filing → |
| FREQ | SELL | 2023-07-19 | $2K | — | Filing → |